吡柔比星治疗晚期非小细胞肺癌的II期试验。西南肿瘤协作组研究。 - Suppr

Suppr

超能文献

Phase II trial of piroxantrone in advanced non-small cell carcinoma of the lung. A Southwest Oncology Group study.

作者信息

Williamson S K, Crowley J J, Livingston R, Hantel A, Doroshow J H

机构信息

University of Kansas Medical Center, Kansas City.

出版信息

Invest New Drugs. 1992 Apr;10(1):29-30. doi: 10.1007/BF01275476.

DOI:10.1007/BF01275476

PMID:1318871

Abstract

摘要

相似文献

Phase II trial of piroxantrone in advanced non-small cell carcinoma of the lung. A Southwest Oncology Group study.吡柔比星治疗晚期非小细胞肺癌的II期试验。西南肿瘤协作组研究。

Invest New Drugs. 1992 Apr;10(1):29-30. doi: 10.1007/BF01275476.

A phase II trial of DuP 937 (Teloxantrone) in non-small cell lung cancer. A study of the NCIC Clinical Trials Group.DuP 937（替洛蒽醌）用于非小细胞肺癌的II期试验。加拿大国家癌症研究所临床试验组的一项研究。

Ann Oncol. 1993 Sep;4(8):693-4. doi: 10.1093/oxfordjournals.annonc.a058627.

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results.紫杉醇、美巴龙和吡柔比星治疗IV期非小细胞肺癌的II期研究：东部肿瘤协作组的结果

J Natl Cancer Inst. 1993 Mar 3;85(5):388-94. doi: 10.1093/jnci/85.5.388.

Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.吡柔比星治疗晚期或转移性软组织肉瘤的II期试验。一项西南肿瘤学组的研究。

Invest New Drugs. 1993 Nov;11(4):337-41. doi: 10.1007/BF00874435.

Phase II evaluation of piroxantrone in renal cell carcinoma. A Southwest Oncology Group Study.吡柔比星用于肾细胞癌的II期评估。西南肿瘤协作组研究。

Invest New Drugs. 1992 Jul;10(2):129-32. doi: 10.1007/BF00873131.

Phase II trial of piroxantrone in gastric carcinoma. A Southwest Oncology Group study.

Invest New Drugs. 1994;12(2):159-61. doi: 10.1007/BF00874449.

A phase II trial of piroxantrone in adenocarcinoma of the pancreas. A Southwest Oncology Group study.

Invest New Drugs. 1993 Nov;11(4):329-31. doi: 10.1007/BF00874432.

Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor.

J Clin Oncol. 1993 Sep;11(9):1795-803. doi: 10.1200/JCO.1993.11.9.1795.

A phase II trial of piroxantrone in advanced ovarian carcinoma after failure of platinum-based chemotherapy: Southwest Oncology Group Study 8904.

Gynecol Oncol. 1995 Jun;57(3):407-11. doi: 10.1006/gyno.1995.1163.

Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trial.吡柔比星用于复发性和转移性头颈部鳞状细胞癌患者的II期试验。一项西南肿瘤协作组试验。

Invest New Drugs. 1993 May-Aug;11(2-3):227-9. doi: 10.1007/BF00874161.

引用本文的文献

Invest New Drugs. 1993 Nov;11(4):337-41. doi: 10.1007/BF00874435.

Phase II trial of piroxantrone in metastatic breast cancer. A Southwest Oncology Group study.

Invest New Drugs. 1994;12(4):333-6. doi: 10.1007/BF00873050.

本文引用的文献

Reporting results of cancer treatment.癌症治疗结果报告。

Cancer. 1981 Jan 1;47(1):207-14. doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6.

5-[(Aminoalkyl)amino]-substituted anthra[1,9-cd]pyrazol-6(2H)-ones as novel anticancer agents. Synthesis and biological evaluation.5-[(氨基烷基)氨基]取代的蒽并[1,9-cd]吡唑-6(2H)-酮作为新型抗癌剂。合成与生物学评价。

J Med Chem. 1984 Mar;27(3):253-5. doi: 10.1021/jm00369a002.

Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.蒽吡唑类，一类新型的嵌入剂，对鼠类肿瘤具有高效、广谱活性。

Cancer Res. 1985 Nov;45(11 Pt 1):5532-9.

In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles).一类新型DNA络合剂——蒽并[1,9-cd]吡唑-6(2H)-酮（蒽吡唑）对L1210白血病细胞的体外DNA链断裂及核酸合成抑制作用

Biochem Pharmacol. 1985 Oct 1;34(19):3499-508. doi: 10.1016/0006-2952(85)90724-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验